Proof-of-principle of a technology transfer of a dried blood virus neutralisation assay to a Gavi-eligible country
We show successful transfer of an RSV neutralisation assay, thereby strengthening the laboratory research capacity in a Gavi-eligible country. Reliable measurement of RSV neutralising antibodies in a Gavi-eligible country and the use of dried blood can contribute to inclusion of LMICs in RSV vaccine development and access.
Authors
- Natalie I Mazur (ORCID: https://orcid.org/0000-0002-3233-908X)
- Eveline M. Delemarre (ORCID: https://orcid.org/0000-0002-4310-0998)
- Louis Bont (ORCID: https://orcid.org/0000-0003-3099-4475)
- John Kofi Odoom (ORCID: https://orcid.org/0000-0003-0761-4614)
- Jonne Terstappen (ORCID: https://orcid.org/0000-0003-2986-0138)
- Anouk Versnel (ORCID: https://orcid.org/0009-0002-1529-7137)
- Evangeline Obodai (ORCID: https://orcid.org/0000-0001-5358-5688)
- Jude Yayra Mensah
- Comfort Nuamah Antwi
- Daniela Cianci
- Peter M. van de Ven
Institutions
- University of Ghana (GH)
- University Medical Center Utrecht (NL)
- Noguchi Memorial Institute for Medical Research (GH)
Publication Details
- Journal
- BMJ Global Health
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1136/bmjgh-2024-016916
- Primary Topic
- Viral Infections and Outbreaks Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00